Lv11
30 积分 2024-03-02 加入
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management
56分钟前
求助中
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2小时前
已完结
Upadacitinib in Crohn’s disease: needs more insight
4小时前
已关闭
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
4小时前
已完结
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
1个月前
已完结
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
3个月前
已完结
Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy from the American Academy of Ophthalmology's Task Force
5个月前
已关闭
Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus
11个月前
已完结
Childhood-onset systemic lupus erythematosus in China, 2016–21: a nationwide study
1年前
已完结
Relationship between clinical manifestations and serological profile in patients affected by Systemic Lupus Erythematosus
1年前
已完结
皖公网安备34019202002308
